139 related articles for article (PubMed ID: 3170033)
1. Comparative study of plasminogen activator antigens in colonic carcinomas and adenomas.
Suzumiya J; Hasui Y; Kohga S; Sumiyoshi A; Hashida S; Ishikawa E
Int J Cancer; 1988 Oct; 42(4):627-32. PubMed ID: 3170033
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator profiles in neoplastic tissues of the human colon.
de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Dooijewaard G; van den Ingh HF; Lamers CB
Cancer Res; 1988 Aug; 48(16):4520-4. PubMed ID: 3260815
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Lamers CB
Cancer Res; 1987 Sep; 47(17):4654-7. PubMed ID: 3621160
[TBL] [Abstract][Full Text] [Related]
4. A model for human colon carcinoma evolution based on the differential response of cultured preneoplastic, premalignant, and malignant cells to 12-O-tetradecanoylphorbol-13-acetate.
Friedman E; Urmacher C; Winawer S
Cancer Res; 1984 Apr; 44(4):1568-78. PubMed ID: 6423277
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum.
Sier CF; Fellbaum C; Verspaget HW; Schmitt M; Griffioen G; Graeff H; Hôfler H; Lamers CB
Histopathology; 1991 Sep; 19(3):231-7. PubMed ID: 1916697
[TBL] [Abstract][Full Text] [Related]
6. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas.
Kopp R; Noelke B; Sauter G; Schildberg FW; Paumgartner G; Pfeiffer A
Cancer Res; 1991 Jan; 51(1):205-10. PubMed ID: 1988085
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells.
Koretz K; Möller P; Schwartz-Albiez R
Eur J Cancer; 1993; 29A(8):1184-9. PubMed ID: 8518031
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme.
Sim PS; Stephens RW; Fayle DR; Doe WF
Int J Cancer; 1988 Oct; 42(4):483-8. PubMed ID: 3139573
[TBL] [Abstract][Full Text] [Related]
9. Role of urokinase in colorectal neoplasia.
Gelister JS; Jass JR; Mahmoud M; Gaffney PJ; Boulos PB
Br J Surg; 1987 Jun; 74(6):460-3. PubMed ID: 3111578
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of lysozyme production in colonic adenomas and adenocarcinomas.
Yuen ST; Wong MP; Chung LP; Chan SY; Cheung N; Ho J; Leung SY
Histopathology; 1998 Feb; 32(2):126-32. PubMed ID: 9543668
[TBL] [Abstract][Full Text] [Related]
11. Enzyme activities in biopsy specimens from large-bowel mucosa in colorectal adenomas and carcinomas.
Børkje B; Laerum OD; Schrumpf E
Scand J Gastroenterol; 1987 Jun; 22(5):533-8. PubMed ID: 3629177
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.
Sier CF; Verspaget HW; Griffioen G; Verheijen JH; Quax PH; Dooijewaard G; De Bruin PA; Lamers CB
Gastroenterology; 1991 Dec; 101(6):1522-8. PubMed ID: 1955118
[TBL] [Abstract][Full Text] [Related]
13. Relationship of ornithine decarboxylase activity and human colon tumorigenesis.
Takami H; Koudaira H; Kodaira S
Jpn J Clin Oncol; 1994 Jun; 24(3):141-3. PubMed ID: 8007423
[TBL] [Abstract][Full Text] [Related]
14. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC
Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414
[TBL] [Abstract][Full Text] [Related]
15. Disparities of conjugating protective enzyme activities in the colon of patients with adenomas and carcinomas.
Hoensch HP; Roelofs HM; Edler L; Kirch W; Peters WH
World J Gastroenterol; 2013 Sep; 19(36):6020-5. PubMed ID: 24106402
[TBL] [Abstract][Full Text] [Related]
16. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
Ganesh S; Sier CF; Heerding MM; van Krieken JH; Griffioen G; Welvaart K; van de Velde CJ; Verheijen JH; Lamers CB; Verspaget HW
Br J Cancer; 1997; 75(12):1793-801. PubMed ID: 9192984
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
Bergheim I; Bode C; Parlesak A
BMC Gastroenterol; 2005 Nov; 5():34. PubMed ID: 16281975
[TBL] [Abstract][Full Text] [Related]
18. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
Rodrigues S; Rodrigue CM; Attoub S; Fléjou JF; Bruyneel E; Bracke M; Emami S; Gespach C
Oncogene; 2006 Oct; 25(50):6628-36. PubMed ID: 16715141
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
[TBL] [Abstract][Full Text] [Related]
20. Development of oxygen insensitivity of the quantitative histochemical assay of G6PDH activity during colorectal carcinogenesis.
Van Driel BE; De Goeij AF; Song JY; De Bruïne AP; Van Noorden CJ
J Pathol; 1997 Aug; 182(4):398-403. PubMed ID: 9306960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
